Individuals Coming Off Weight-Loss Jabs Put On Pounds at a Quadrupled Rate Compared to People Using Diet and Exercise

New research reveals that people who come off blockbuster GLP-1 drugs like Mounjaro or Wegovy can put back on shed pounds much more quickly than those who stop conventional lifestyle programs.

Research printed in a prominent medical journal shows that while overweight people frequently drop substantial amounts of their body weight while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month upon discontinuation.

"People purchasing these medications must be cognizant of the potential of quick rebound weight gain when the therapy ends," warns expert Dr. Susan Jebb.

Such speed of regain suggests a reversion to original mass within about one and a half years.

Analyzing Treatments

The analysis, which examined dozens of trials involving thousands of patients, contrasted the outcomes of the injectable medications with other pills.

Researchers point out that individuals who shed pounds through diet and exercise typically see a more gradual weight regain—approximately 0.1 kg a month—once they finish.

Understanding the Fast Rebound

Doctors propose the way of the injections is key to understanding the accelerated rebound.

The injections mimic a natural hormone called GLP-1, which controls feelings of fullness.

"Long-term administration of GLP-1 concentrations several times higher than the body's typical production could lead to the system to generate a reduced amount of its own natural GLP-1, and could lessen sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this GLP-1 'fix' results in hunger is unsuppressed, making binge eating far more likely."

An Ongoing Issue?

Health authorities suggest the injections for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Many experts argue that, given the significant potential of relapse, the therapy should be considered ongoing.

This view is supported by pharmaceutical companies, who say that the findings "underscore the long-term character of obesity," akin to managing conditions like high blood pressure.

User Accounts

Users who have come off the medication report a powerful resurgence of hunger.

"I experienced a trigger that goes on and I was suddenly extremely hungry," said one woman.

The struggle is compounded if patients have not established permanent lifestyle or habit changes during treatment.

Growing Interest

Survey data indicate that a significant number of adults in the UK have used these injections in the past year, with desire continuing to grow.

• Use is more common among females than men.
• The middle-aged age group shows the greatest level of interest.
• A large proportion access the drugs through private prescriptions rather than the NHS.

Ultimately, experts caution that while these medications are potent agents for shedding pounds, they are not a magic fix and long-term success hinges on ongoing lifestyle support.